Christopher J. Senner Exelixis, Inc. (EXEL) insider trading activity

Christopher J. Senner is EVP and CFO of EXELIXIS, INC.. Currently has a direct ownership of 967,842 shares of EXEL, which is worth approximately $37.4 Million. The most recent transaction as insider was on Apr 03, 2023, when has been sold 85,414 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 968K

0% 3M change

34.11% 12M change

Total Value Held $37.4 Million

Christopher J. Senner Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 03 2023	BUY Grant, award, or other acquisition	-	85,414 Added 12.64%	590,077 Common Stock
Feb 15 2023	SELL Payment of exercise price or tax liability	$95,426 $18.08 p/Share	5,278 Reduced 1.04%	504,663 Common Stock
Nov 15 2022	SELL Payment of exercise price or tax liability	$134,916 $16.71 p/Share	8,074 Reduced 1.56%	509,941 Common Stock
Aug 11 2022	SELL Payment of exercise price or tax liability	$2,939,632 $19.23 p/Share	152,867 Reduced 22.79%	518,015 Common Stock
Aug 11 2022	BUY Exercise of conversion of derivative security	$1,397,250 $6.21 p/Share	225,000 Added 25.11%	670,882 Common Stock
Aug 03 2022	SELL Payment of exercise price or tax liability	$173,510 $21.49 p/Share	8,074 Reduced 1.78%	445,882 Common Stock
Aug 03 2022	BUY Grant, award, or other acquisition	-	32,567 Added 6.69%	453,956 Common Stock
May 15 2022	SELL Payment of exercise price or tax liability	$169,556 $20.08 p/Share	8,444 Reduced 1.96%	421,389 Common Stock
Mar 04 2022	BUY Grant, award, or other acquisition	-	75,985 Added 15.02%	429,833 Common Stock
Feb 15 2022	SELL Payment of exercise price or tax liability	$340,699 $18.59 p/Share	18,327 Reduced 4.92%	353,848 Common Stock
Dec 15 2021	SELL Payment of exercise price or tax liability	$87,227 $17.0 p/Share	5,131 Reduced 1.36%	372,175 Common Stock
Dec 15 2021	BUY Grant, award, or other acquisition	-	19,491 Added 4.91%	377,306 Common Stock
Nov 15 2021	SELL Payment of exercise price or tax liability	$1,044,605 $18.1 p/Share	57,713 Reduced 13.89%	357,815 Common Stock
Sep 30 2021	SELL Payment of exercise price or tax liability	$176,861 $20.63 p/Share	8,573 Reduced 2.02%	415,528 Common Stock
Sep 30 2021	BUY Grant, award, or other acquisition	-	32,567 Added 7.13%	424,101 Common Stock
Sep 21 2021	SELL Payment of exercise price or tax liability	$1,119,309 $20.33 p/Share	55,057 Reduced 12.33%	391,534 Common Stock
Sep 21 2021	BUY Exercise of conversion of derivative security	$329,400 $3.66 p/Share	90,000 Added 16.77%	446,591 Common Stock
Mar 04 2021	BUY Grant, award, or other acquisition	-	64,150 Added 15.25%	356,591 Common Stock
Feb 15 2021	SELL Payment of exercise price or tax liability	$89,941 $21.91 p/Share	4,105 Reduced 1.38%	292,441 Common Stock
Feb 03 2021	SELL Payment of exercise price or tax liability	$410,727 $22.56 p/Share	18,206 Reduced 5.78%	296,546 Common Stock
Feb 03 2021	BUY Grant, award, or other acquisition	-	69,156 Added 18.01%	314,752 Common Stock
Jan 12 2021	SELL Open market or private sale	$750,000 $25.0 p/Share	30,000 Reduced 10.89%	245,596 Common Stock
Jan 12 2021	BUY Exercise of conversion of derivative security	$109,800 $3.66 p/Share	30,000 Added 9.82%	275,596 Common Stock
Nov 15 2020	SELL Payment of exercise price or tax liability	$274,116 $20.16 p/Share	13,597 Reduced 5.25%	245,596 Common Stock
Oct 22 2020	SELL Payment of exercise price or tax liability	$1,022,387 $21.79 p/Share	46,920 Reduced 15.33%	259,193 Common Stock

Also insider at

CRTX

Cortexyme, Inc. Healthcare

CJS